Tea polyphenols

About us
Green tea extract
civilization of tea
Herb extract
Biochemistry products
Chinese herb
Material base
Equipment
E-shopping
corona-fz@263.net
Chinese
BIG5

 

DOSAGE OF ANTICANCER HERBAL

PART A PART B PART C
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pingying: Suimiya
English: Blushred Rabdosia
Latin: Rabdosia rubescens (Hemsl.) Hara

Sources: The whole plant of Rabdosia rubescens (Hemsl.) Hara (Plectranthus rubescens Hemsl.) Family Labiatae.

Constituents: Containing rubescensine, etc.

Actions:
Rubescensine has anticancer action against EAC, S180, HepS and ARS murine tumors. In vitro, it has cytotxicity activity against CaEs-17 human esophageal cancer cell line, at 2 and 3ug/ml, the inhibiting rates were 40% and 75%.

Indications:It could be used for treatment of esophageal, liver cancer and leukemia. The tablet of the herb was 5g crude herb/tab, 2~3tabs/once. t. i. d administered orally for treatment cancers. The results showed that, the symptoms were relieved, the tumor size was stable or reduced, the life span was prolonged. 43 cases of esophageal cancer were treated in Henan province, the effetive cases were 15, the effective rate was 34.8%, 25 cases of cardiac cancer, effective cases were 10, effective rate 40%. 7 cases of esophageal cancer, effective cases were 2, effective rate was 28.6%. 50 cases of various kinds of cancers were divided into two groups, 36 cases were treated with the herb only, 1 case was PR, 12 cases were MR, the total effective rate was 36.1%, 14 cases were treated with the herb combined with chemotherapy, 1 case was PR, 8 cases were MR, the total effective rate was 64.3%. The curative effect on breast cancer of the drug
could be considered best. In addition, granular, syrup and injection preparation were same as tablets.

31 cases of primary liver cancer were treated with various kinds of preparations of the herb. The syrup (1:1 concentration)30ml/once, t. i. d.1 ~3 months were one course of treatment. The injection preparation, 75~100mg/once, disolved in 5%~10% glucose 500ml with iv-drip; rubescensine tablets, 5 tabs/once, t. i. d, one course of treatment was 2 months. The results showed that 27 cases have been followed up, their survival rate of 0.5 year was 29.6%, 1 year was 12%, 2 years 10%. In general, the improving of symptoms, prolonging life span and certain curative action were obtained, no significant toxicity was found.

  
 

All Copy: FuZhou Corona Science & Technology Development Co.,Ltd.
Head Office Tel:  86-591-8376-9772 ;  8376-9751    Fax:  86-591-8376-9723
Copyright© 2001-2008 All right reserved